< Back to latest news & events

News

EPO Annual Fee Increases

February 2024

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024.

The majority of fees will increase by around 4%. Notable exceptions are the 3rd, 4th, and 5th year renewal fees which will rise by 30%, 28%, and 8% retrospectively.

wdt_ID EPO Fee Fee (€) before 1 April 2024 Fee (€) from 1 April 2024 EURO increase % increase
1 Renewal fee for the 3rd year 530 690 160 30%
3 Renewal fee for the 4th year 660 845 185 28%
4 Renewal fee for the 5th year 925 1000 75 8%

In some cases, applicants may want to consider the timing for paying fees in relation to their applications to maximise any opportunities to pay lower official fees. If you would like advice on this, please contact your usual HGF attorney.

Click the button below to find out more.

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article